Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderik F Viergever

Showing results (31-40 of 32) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 32 results.
HIV Clinical Trials|June 3, 2009
Changes in hematological parameters after switching treatment of HIV-infected patients from zidovudine to abacavir or tenofovir DFRoderik F Viergever, Maarten J ten Berg, Wouter W van Solinge, et al.
Lancet (London, England)|May 24, 2013
Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?John-Arne Røttingen, Sadie Regmi, Mari Eide, et al.
Pageof 4

Showing results (31-40 of 32) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 32 results.
HIV Clinical Trials|June 3, 2009
Changes in hematological parameters after switching treatment of HIV-infected patients from zidovudine to abacavir or tenofovir DFRoderik F Viergever, Maarten J ten Berg, Wouter W van Solinge, et al.
Lancet (London, England)|May 24, 2013
Mapping of available health research and development data: what's there, what's missing, and what role is there for a global observatory?John-Arne Røttingen, Sadie Regmi, Mari Eide, et al.
Pageof 4